David Steinberg
Stock Analyst at Jefferies
(1.83)
# 1,993
Out of 4,667 analysts
35
Total ratings
61.54%
Success rate
23.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Upgrades: Buy | $9 → $16 | $8.19 | +95.36% | 6 | Sep 20, 2023 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $27.15 | +132.04% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $36.12 | +10.74% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $119.24 | +57.67% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $8.78 | -8.88% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $3.36 | +257.14% | 2 | Jun 14, 2018 | |
| OPTN OptiNose | Initiates: Buy | $27 | $0.37 | +7,256.95% | 1 | Nov 7, 2017 | |
| SVRA Savara | Initiates: Buy | $20 | $3.13 | +538.98% | 1 | Sep 22, 2017 |
Bausch Health Companies
Sep 20, 2023
Upgrades: Buy
Price Target: $9 → $16
Current: $8.19
Upside: +95.36%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $27.15
Upside: +132.04%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $36.12
Upside: +10.74%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $119.24
Upside: +57.67%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $8.78
Upside: -8.88%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $3.36
Upside: +257.14%
OptiNose
Nov 7, 2017
Initiates: Buy
Price Target: $27
Current: $0.37
Upside: +7,256.95%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $3.13
Upside: +538.98%